Exacerbations of asthma might in part be driven by IL-33, e.g., through its action on mast cells[48], why administration of this type of cytokine vaccine may prove to be an effective therapeutic tool for treating allergic asthma, as well as other phenotypes of asthma where IL-33 also are implicated[28]. The gene discussed is IL33; the disease is asthma.